Richard G. Chiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Richard G. Chiu has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Victoria S. Lee
Department of Otolaryngology University of Illinois Chicago Chicago Illinois USA
6 shared publications Kamal Eldeirawi
Department of Population Health Nursing Science College of Nursing, University of Illinois Chicago Chicago Illinois USA
5 shared publicationsSharmilee M. Nyenhuis
Department of Pediatrics, Section of Allergy and Immunology University of Chicago Chicago Illinois USA
5 shared publicationsAnthony I. Dick
Department of Otolaryngology College of Medicine, University of Illinois Chicago Chicago Illinois USA
4 shared publicationsRachel Caskey
Department of Medicine College of Medicine, University of Illinois Chicago Chicago Illinois USA
3 shared publicationsThasarat Sutabutr Vajaranant
Department of Ophthalmology and Visual Sciences College of Medicine, University of Illinois Chicago Chicago Illinois USA
3 shared publications
Latest Publications
- Open Access
- 12 November 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 174 (2) , 347-358
Association of Menopause and Hormonal Contraceptive Use With Chronic Rhinosinusitis: An “All of Us” Analysis
Objective: The role of sex hormones in inflammation has attracted increased attention, but the impact of hormone‐modifying states in chronic rhinosinusitis (CRS) has not been thoroughly studied. We aim to investigate the association of menopause and systemic hormonal contraceptive (SHC) use with both CRS with (CRSwNP) and without (CRSsNP) nasal polyps. Study Design: Cross‐sectional analysis of data. Setting: A large, national dataset of adults from the All of Us Research Program. Methods: This study was conducted using data from 239,564 participants. CRS diagnoses, biomarker data, menopause status, and SHC use, including both estrogen‐containing contraceptives (ECCs) and progestin‐only contraceptives (POCs), were extracted. Multivariable logistic and linear regression models were constructed to analyze the associations of CRS diagnosis and biomarkers with menopause and SHC use. Results: Postmenopausal participants had no significant difference in CRS odds compared to premenopausal patients (odds ratio [OR]: 1.02; 95% confidence interval [CI]: 0.94‐1.11). Compared to no SHC use, POCs were not associated with CRS, but ECC use was associated with a lower odds of CRSsNP (OR: 0.71; 95% CI: 0.64‐0.80) while being not associated with CRSwNP (OR: 0.82; 95% CI: 0.51‐1.25). Biomarker analysis revealed that ECC use was associated with a decreased serum neutrophil concentration among participants without CRS ( β : −1.29; 95% CI: −1.72 to −0.85) and among participants with CRSsNP ( β : −1.66; 95% CI: −3.02 to −0.29) compared to no SHC use. Conclusion: Menopause was not associated with CRS, while ECC use was associated with a lower odds of CRSsNP. Further research is needed to clarify underlying mechanisms.
- 12 November 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 174 (2) , 347-358
Open AccessAssociation of Menopause and Hormonal Contraceptive Use With Chronic Rhinosinusitis: An “All of Us” Analysis
Objective: The role of sex hormones in inflammation has attracted increased attention, but the impact of hormone‐modifying states in chronic rhinosinusitis (CRS) has not been thoroughly studied. We aim to investigate the association of menopause and systemic hormonal contraceptive (SHC) use with both CRS with (CRSwNP) and without (CRSsNP) nasal polyps. Study Design: Cross‐sectional analysis of data. Setting: A large, national dataset of adults from the All of Us Research Program. Methods: This study was conducted using data from 239,564 participants. CRS diagnoses, biomarker data, menopause status, and SHC use, including both estrogen‐containing contraceptives (ECCs) and progestin‐only contraceptives (POCs), were extracted. Multivariable logistic and linear regression models were constructed to analyze the associations of CRS diagnosis and biomarkers with menopause and SHC use. Results: Postmenopausal participants had no significant difference in CRS odds compared to premenopausal patients (odds ratio [OR]: 1.02; 95% confidence interval [CI]: 0.94‐1.11). Compared to no SHC use, POCs were not associated with CRS, but ECC use was associated with a lower odds of CRSsNP (OR: 0.71; 95% CI: 0.64‐0.80) while being not associated with CRSwNP (OR: 0.82; 95% CI: 0.51‐1.25). Biomarker analysis revealed that ECC use was associated with a decreased serum neutrophil concentration among participants without CRS ( β : −1.29; 95% CI: −1.72 to −0.85) and among participants with CRSsNP ( β : −1.66; 95% CI: −3.02 to −0.29) compared to no SHC use. Conclusion: Menopause was not associated with CRS, while ECC use was associated with a lower odds of CRSsNP. Further research is needed to clarify underlying mechanisms.
- Open Access
- 21 April 2025
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 46 (3) , 104638
Association of nasal surgery with olfactory function among older adults
- 21 April 2025
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 46 (3) , 104638
Open AccessAssociation of nasal surgery with olfactory function among older adults
- Open Access
- 21 March 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (2) , e70123
Systemic Hormonal Contraceptive Use and Rhinitis Among Adult Women: An All of Us Database Analysis
Objectives: The role of sex hormones in the pathogenesis of allergic and inflammatory conditions such as rhinitis has been receiving increased attention, with evidence supporting an inflammation‐modulating role of estrogen and progesterone in the nasal mucosa. However, the specific influence of hormonal contraceptives in rhinitis has been sparsely studied. As such, we sought to investigate the association of systemic hormonal contraceptives with both allergic (AR) and nonallergic rhinitis (NAR) using a national data set of adults in the United States.Methods: This study was conducted using data from 46,205 female participants aged 20–40 in the All of Us Research Program. Rhinitis diagnoses, systemic hormonal contraceptive use, and covariate data were extracted for all participants. These variables were included in multivariable logistic regression models assessing the association of any systemic hormonal contraceptive use with rhinitis, both AR and NAR. Separate models were conducted to examine the association of progestin‐only contraceptives (POCs) and estrogen‐containing contraceptives (ECCs) on the odds of rhinitis. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated.Results: Systemic hormonal contraceptives were associated with AR (OR: 1.32; 95% CI: 1.20–1.44) but not NAR (OR: 1.20; 95% CI: 0.90–1.56) after controlling for covariates. When analyzing POCs and ECCs separately, both were associated with AR compared to those not taking any systemic hormonal contraceptives (OR: 1.29; 95% CI: 1.12–1.48 for POC, OR: 1.35; 95% CI: 1.21–1.51 for ECC) but were not significantly associated with NAR (OR: 1.04; 95% CI: 0.66–1.57 for POC, OR: 1.33; 95% CI: 0.95–1.81 for ECC).Conclusion: Systemic hormonal contraceptive use was independently associated with AR, with no significant difference between POCs and ECCs, while not being associated with NAR. Our findings may support a hormonal role in the pathogenesis of AR, but further research is needed to establish causation and understand the underlying mechanisms linking systemic hormonal contraceptive use to AR.Level of Evidence: 3.
- 21 March 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (2) , e70123
Open AccessSystemic Hormonal Contraceptive Use and Rhinitis Among Adult Women: An All of Us Database Analysis
Objectives: The role of sex hormones in the pathogenesis of allergic and inflammatory conditions such as rhinitis has been receiving increased attention, with evidence supporting an inflammation‐modulating role of estrogen and progesterone in the nasal mucosa. However, the specific influence of hormonal contraceptives in rhinitis has been sparsely studied. As such, we sought to investigate the association of systemic hormonal contraceptives with both allergic (AR) and nonallergic rhinitis (NAR) using a national data set of adults in the United States.Methods: This study was conducted using data from 46,205 female participants aged 20–40 in the All of Us Research Program. Rhinitis diagnoses, systemic hormonal contraceptive use, and covariate data were extracted for all participants. These variables were included in multivariable logistic regression models assessing the association of any systemic hormonal contraceptive use with rhinitis, both AR and NAR. Separate models were conducted to examine the association of progestin‐only contraceptives (POCs) and estrogen‐containing contraceptives (ECCs) on the odds of rhinitis. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated.Results: Systemic hormonal contraceptives were associated with AR (OR: 1.32; 95% CI: 1.20–1.44) but not NAR (OR: 1.20; 95% CI: 0.90–1.56) after controlling for covariates. When analyzing POCs and ECCs separately, both were associated with AR compared to those not taking any systemic hormonal contraceptives (OR: 1.29; 95% CI: 1.12–1.48 for POC, OR: 1.35; 95% CI: 1.21–1.51 for ECC) but were not significantly associated with NAR (OR: 1.04; 95% CI: 0.66–1.57 for POC, OR: 1.33; 95% CI: 0.95–1.81 for ECC).Conclusion: Systemic hormonal contraceptive use was independently associated with AR, with no significant difference between POCs and ECCs, while not being associated with NAR. Our findings may support a hormonal role in the pathogenesis of AR, but further research is needed to establish causation and understand the underlying mechanisms linking systemic hormonal contraceptive use to AR.Level of Evidence: 3.
- Open Access
- 11 March 2025
- Published by Elsevier in World Neurosurgery
- Vol. 196, 123738
Trend Toward Vaginal Versus Cesarean Deliveries in Pregnant Patients with Unruptured Intracranial Aneurysms in the 2010s: A Nationwide Inpatient Analysis
- 11 March 2025
- Published by Elsevier in World Neurosurgery
- Vol. 196, 123738
Open AccessTrend Toward Vaginal Versus Cesarean Deliveries in Pregnant Patients with Unruptured Intracranial Aneurysms in the 2010s: A Nationwide Inpatient Analysis
- Open Access
- 24 January 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (6) , 1935-1939
Association of Menopause and Rhinitis Among Adult Women in the United States: Findings from the All of Us Research Program
Objective: The inflammatory role of female hormones has been garnering increased attention in the literature. Studies suggest a link between estrogen and inflammatory conditions of the airways and nasal mucosa. However, there remains a paucity of literature regarding the associations of hormones with rhinitis. Given the profound hormonal changes that occur during menopause, we sought to better understand the association between menopause and rhinitis.Methods: Data from the All of Us Research Program regarding rhinitis diagnoses, menopause status, demographic variables, socioeconomic status, and comorbidities were extracted for female participants aged 40–60. Crude odds ratios (cORs) and 95% confidence intervals (CIs) were calculated for unadjusted associations between menopause and rhinitis. Variables were then included in multivariable logistic regression models, with separate models for allergic rhinitis (AR) and nonallergic rhinitis (NAR) as the outcome variables. Adjusted odds ratios (aOR) and 95% CI were calculated.Results: We identified 40,875 female participants aged 40–60 without any missing data. Compared with participants without rhinitis, a greater proportion of those with AR (51.6% vs. 55.6%; cOR: 1.18; 95% CI: 1.11–1.25) and NAR (51.6% vs. 58.9%; cOR: 1.34; 95% CI: 1.11–1.63) had experienced menopause. However, after controlling for covariates, menopause was associated with a decreased odds of AR (aOR: 0.89; 95% CI: 0.82–0.96) and not associated with NAR (aOR: 0.98; 95% CI: 0.77–1.24).Conclusion: Menopause was independently associated with a decreased odds of AR but was not associated with NAR. Research should aim to further examine these relationships and hormonal mechanisms underlying the observed protective associations.Level of Evidence: 3 Laryngoscope, 135:1935–1939, 2025
- 24 January 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (6) , 1935-1939
Open AccessAssociation of Menopause and Rhinitis Among Adult Women in the United States: Findings from the All of Us Research Program
Objective: The inflammatory role of female hormones has been garnering increased attention in the literature. Studies suggest a link between estrogen and inflammatory conditions of the airways and nasal mucosa. However, there remains a paucity of literature regarding the associations of hormones with rhinitis. Given the profound hormonal changes that occur during menopause, we sought to better understand the association between menopause and rhinitis.Methods: Data from the All of Us Research Program regarding rhinitis diagnoses, menopause status, demographic variables, socioeconomic status, and comorbidities were extracted for female participants aged 40–60. Crude odds ratios (cORs) and 95% confidence intervals (CIs) were calculated for unadjusted associations between menopause and rhinitis. Variables were then included in multivariable logistic regression models, with separate models for allergic rhinitis (AR) and nonallergic rhinitis (NAR) as the outcome variables. Adjusted odds ratios (aOR) and 95% CI were calculated.Results: We identified 40,875 female participants aged 40–60 without any missing data. Compared with participants without rhinitis, a greater proportion of those with AR (51.6% vs. 55.6%; cOR: 1.18; 95% CI: 1.11–1.25) and NAR (51.6% vs. 58.9%; cOR: 1.34; 95% CI: 1.11–1.63) had experienced menopause. However, after controlling for covariates, menopause was associated with a decreased odds of AR (aOR: 0.89; 95% CI: 0.82–0.96) and not associated with NAR (aOR: 0.98; 95% CI: 0.77–1.24).Conclusion: Menopause was independently associated with a decreased odds of AR but was not associated with NAR. Research should aim to further examine these relationships and hormonal mechanisms underlying the observed protective associations.Level of Evidence: 3 Laryngoscope, 135:1935–1939, 2025
- Open Access
- 31 December 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (4) , 950-952.e1
Biological sex differences in rhinitis prevalence among adults in the United States: An “All of Us” Research Program database analysis
- 31 December 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (4) , 950-952.e1
Open AccessBiological sex differences in rhinitis prevalence among adults in the United States: An “All of Us” Research Program database analysis
- 6 September 2024
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 98, 158-160
Prompt engineering to increase GPT3.5’s performance on the Plastic Surgery In-Service Exams
- 6 September 2024
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 98, 158-160
Prompt engineering to increase GPT3.5’s performance on the Plastic Surgery In-Service Exams
- Open Access
- 27 July 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (4) , e1311
Association of prior military service with olfactory function among older adults
Objective: Olfactory dysfunction (OD) is a condition primarily affecting older adults. Several factors have been implicated in OD, such as age, socioeconomic status, and neurodegenerative disease; however, the effect of military service still requires additional investigation. Here, we aim to determine if there is an association between prior military service and OD among older adults.Methods: This cross‐sectional study included 2268 adults from Round 1 of the National Social Life, Health, and Aging Project. OD was defined as 0–3 odors correctly identified on the 5‐item Sniffin' Sticks test. Bivariate analysis was conducted to calculate crude odds ratios (cOR) for the association of prior military service with OD and identify covariates for regression. Associations between prior military service and OD were assessed using logistic regression, and adjusted odds ratios (aOR) were calculated controlling for age, gender, race/ethnicity, education, stroke history, dementia, diabetes, and mental health. All analyses were weighted using survey weights to account for sampling design.Results: OD was present in 489 adults (21.6%). Among those with OD, the average age was 71.0 ± 7.9 years, whereas the average age in those without OD was 67.0 ± 7.2 years. Among adults with OD, 34.4% reported prior military service, compared to 27.7% of adults without OD (cOR = 1.37; 95% CI: 1.05–1.79). However, after adjusting for covariates, prior military service was not associated with OD (aOR: 1.09; 95% CI: 0.79–1.50). Older age (aOR: 1.07; 95% CI: 1.05–1.09) and worse mental health (aOR: 1.68; 95% CI: 1.14–2.49) were associated with OD.Conclusion: Prior military service was not associated with OD among older adults after controlling for covariates. More nuanced research is needed to examine correlations between OD and specific elements of military service such as duration, toxin exposure, and head trauma.Level of Evidence: Level 4.
- 27 July 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (4) , e1311
Open AccessAssociation of prior military service with olfactory function among older adults
Objective: Olfactory dysfunction (OD) is a condition primarily affecting older adults. Several factors have been implicated in OD, such as age, socioeconomic status, and neurodegenerative disease; however, the effect of military service still requires additional investigation. Here, we aim to determine if there is an association between prior military service and OD among older adults.Methods: This cross‐sectional study included 2268 adults from Round 1 of the National Social Life, Health, and Aging Project. OD was defined as 0–3 odors correctly identified on the 5‐item Sniffin' Sticks test. Bivariate analysis was conducted to calculate crude odds ratios (cOR) for the association of prior military service with OD and identify covariates for regression. Associations between prior military service and OD were assessed using logistic regression, and adjusted odds ratios (aOR) were calculated controlling for age, gender, race/ethnicity, education, stroke history, dementia, diabetes, and mental health. All analyses were weighted using survey weights to account for sampling design.Results: OD was present in 489 adults (21.6%). Among those with OD, the average age was 71.0 ± 7.9 years, whereas the average age in those without OD was 67.0 ± 7.2 years. Among adults with OD, 34.4% reported prior military service, compared to 27.7% of adults without OD (cOR = 1.37; 95% CI: 1.05–1.79). However, after adjusting for covariates, prior military service was not associated with OD (aOR: 1.09; 95% CI: 0.79–1.50). Older age (aOR: 1.07; 95% CI: 1.05–1.09) and worse mental health (aOR: 1.68; 95% CI: 1.14–2.49) were associated with OD.Conclusion: Prior military service was not associated with OD among older adults after controlling for covariates. More nuanced research is needed to examine correlations between OD and specific elements of military service such as duration, toxin exposure, and head trauma.Level of Evidence: Level 4.
- Open Access
- 31 March 2024
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (4) , 104271
Association of alcohol use with olfactory function among older adults
- 31 March 2024
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (4) , 104271
Open AccessAssociation of alcohol use with olfactory function among older adults
- Open Access
- 13 March 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (6) , 644
Reducing Sample Size While Improving Equity in Vaccine Clinical Trials: A Machine Learning-Based Recruitment Methodology with Application to Improving Trials of Hepatitis C Virus Vaccines in People Who Inject Drugs
Despite the availability of direct-acting antivirals that cure individuals infected with the hepatitis C virus (HCV), developing a vaccine is critically needed in achieving HCV elimination. HCV vaccine trials have been performed in populations with high incidence of new HCV infection such as people who inject drugs (PWID). Developing strategies of optimal recruitment of PWID for HCV vaccine trials could reduce sample size, follow-up costs and disparities in enrollment. We investigate trial recruitment informed by machine learning and evaluate a strategy for HCV vaccine trials termed PREDICTEE—Predictive Recruitment and Enrichment method balancing Demographics and Incidence for Clinical Trial Equity and Efficiency. PREDICTEE utilizes a survival analysis model applied to trial candidates, considering their demographic and injection characteristics to predict the candidate’s probability of HCV infection during the trial. The decision to recruit considers both the candidate’s predicted incidence and demographic characteristics such as age, sex, and race. We evaluated PREDICTEE using in silico methods, in which we first generated a synthetic candidate pool and their respective HCV infection events using HepCEP, a validated agent-based simulation model of HCV transmission among PWID in metropolitan Chicago. We then compared PREDICTEE to conventional recruitment of high-risk PWID who share drugs or injection equipment in terms of sample size and recruitment equity, with the latter measured by participation-to-prevalence ratio (PPR) across age, sex, and race. Comparing conventional recruitment to PREDICTEE found a reduction in sample size from 802 (95%: 642–1010) to 278 (95%: 264–294) with PREDICTEE, while also reducing screening requirements by 30%. Simultaneously, PPR increased from 0.475 (95%: 0.356–0.568) to 0.754 (95%: 0.685–0.834). Even when targeting a dissimilar maximally balanced population in which achieving recruitment equity would be more difficult, PREDICTEE is able to reduce sample size from 802 (95%: 642–1010) to 304 (95%: 288–322) while improving PPR to 0.807 (95%: 0.792–0.821). PREDICTEE presents a promising strategy for HCV clinical trial recruitment, achieving sample size reduction while improving recruitment equity.
- 13 March 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (6) , 644
Open AccessReducing Sample Size While Improving Equity in Vaccine Clinical Trials: A Machine Learning-Based Recruitment Methodology with Application to Improving Trials of Hepatitis C Virus Vaccines in People Who Inject Drugs
Despite the availability of direct-acting antivirals that cure individuals infected with the hepatitis C virus (HCV), developing a vaccine is critically needed in achieving HCV elimination. HCV vaccine trials have been performed in populations with high incidence of new HCV infection such as people who inject drugs (PWID). Developing strategies of optimal recruitment of PWID for HCV vaccine trials could reduce sample size, follow-up costs and disparities in enrollment. We investigate trial recruitment informed by machine learning and evaluate a strategy for HCV vaccine trials termed PREDICTEE—Predictive Recruitment and Enrichment method balancing Demographics and Incidence for Clinical Trial Equity and Efficiency. PREDICTEE utilizes a survival analysis model applied to trial candidates, considering their demographic and injection characteristics to predict the candidate’s probability of HCV infection during the trial. The decision to recruit considers both the candidate’s predicted incidence and demographic characteristics such as age, sex, and race. We evaluated PREDICTEE using in silico methods, in which we first generated a synthetic candidate pool and their respective HCV infection events using HepCEP, a validated agent-based simulation model of HCV transmission among PWID in metropolitan Chicago. We then compared PREDICTEE to conventional recruitment of high-risk PWID who share drugs or injection equipment in terms of sample size and recruitment equity, with the latter measured by participation-to-prevalence ratio (PPR) across age, sex, and race. Comparing conventional recruitment to PREDICTEE found a reduction in sample size from 802 (95%: 642–1010) to 278 (95%: 264–294) with PREDICTEE, while also reducing screening requirements by 30%. Simultaneously, PPR increased from 0.475 (95%: 0.356–0.568) to 0.754 (95%: 0.685–0.834). Even when targeting a dissimilar maximally balanced population in which achieving recruitment equity would be more difficult, PREDICTEE is able to reduce sample size from 802 (95%: 642–1010) to 304 (95%: 288–322) while improving PPR to 0.807 (95%: 0.792–0.821). PREDICTEE presents a promising strategy for HCV clinical trial recruitment, achieving sample size reduction while improving recruitment equity.